CG Oncology, Inc. (CGON) Net Margin
- 2026-06-30: Net Margin -6832.84%.
- 2026-03-31: Net Margin -5558.82%.
- 2025-12-31: Net Margin -1779.03%.
- 2025-09-30: Net Margin -2629.53%.
Complete source-backed net margin history.
- Available history
- 2023-03-31 to 2026-06-30
- Data captured
Historical Net Margin
| Date | Net Margin |
|---|---|
| 2026-06-30 | -6832.84% |
| 2026-03-31 | -5558.82% |
| 2025-12-31 | -1779.03% |
| 2025-09-30 | -2629.53% |
| 2025-03-31 | -66253.85% |
| 2024-12-31 | -6973.25% |
| 2024-09-30 | -47453.49% |
| 2024-06-30 | -17028.83% |
| 2024-03-31 | -3201.13% |
| 2023-12-31 | -1655500.00% |
| 2023-09-30 | -130755.56% |
| 2023-03-31 | -4469.59% |
Annual Net Margin
| Date | Net Margin |
|---|---|
| 2025-12-31 | -3985.02% |
| 2024-12-31 | -7729.50% |
| 2023-12-31 | -23826.96% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |